Wednesday 12 May 2021

Protagonist Therapeutics Announces Presentation of Updated Results from Phase 2 Study of Rusfertide in Polycythemia Vera, Selected for Oral Presentation at EHA 2021 - Yahoo Finance

Protagonist Therapeutics Announces Presentation of Updated Results from Phase 2 Study of Rusfertide in Polycythemia Vera, Selected for Oral Presentation at EHA 2021  Yahoo Finance

from "phlebotomist" - Google News https://yhoo.it/3fdyI5R

No comments:

Post a Comment